Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.
Sonigra A, Nel HJ, Wehr P, Ramnoruth N, Patel S, van Schie KA, Bladen MW, Mehdi AM, Tesiram J, Talekar M, Rossjohn J, Reid HH, Stuurman FE, Roberts H, Vecchio P, Gourley I, Rigby M, Becart S, Toes RE, Scherer HU, Lê Cao KA, Campbell K, Thomas R.
Sonigra A, et al. Among authors: becart s.
JCI Insight. 2022 Oct 24;7(20):e160964. doi: 10.1172/jci.insight.160964.
JCI Insight. 2022.
PMID: 36278483
Free PMC article.
Clinical Trial.